SelectQuote Inc. (SLQT) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$0.36 -1.38% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.36

SelectQuote Inc. (SLQT) carries a Roarable Rating of D- (Sell) with 39/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- β€’ RED ALERT Cap $64.0M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on SLQT Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is SLQT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, SelectQuote Inc. (NYSE: SLQT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $0.36 (-1.38% 1D, market cap $64.0M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 4/20, and SEC Balance-Sheet Forensics 6/20. Across 1096 tracked Financials issuers, SLQT ranks #929 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does SLQT compare to RDZN and HIT in the Financials sector?
β–Ό

Within the Financials sector (Specialty Insurers), SLQT carries a Roarable D- (39/100 RQD), trailing P/E of N/A, gross margin of β€”, and ROIC of 7.4%. By comparison, RDZN (Roadzen Inc.) holds a E grade (20/100 RQD, P/E N/A, ROIC -35.0%, cap $97.1M) and HIT (Health In Tech Inc. (Class A)) posts a D+ grade (56/100 RQD, P/E 31.2x, ROIC 7.5%, cap $37.7M). Among the 5-stock peer group, HIT leads on earnings multiple (31.2x) while HIT leads on capital efficiency (7.5% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for SLQT?
β–Ό

Per SLQT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001794783), SelectQuote Inc. generated $1.53B in revenue (+15.5% YoY), $47.6M in net income, and -$13.9M in free cash flow against $1.35B in total assets and $385.7M in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $0.36 (-0.44%)🧬 Dilution Drag (+1.64% YoY Shares)βš™οΈ Cash Engine: 5/20 (E) β€’ 0% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (39/100 Β· D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.6% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERRED ALERT β€’ D-
025507510039
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- Β· Rk D-
Cash (5)Whales (11)SEC (13)Macro (4)CEO (6)
Each axis scored 0–20
12M PRICE TARGET CONE-8.3% Base Target
$2 Bull$0 Base$0 Bear
πŸ“¬ FREE SLQT RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for SLQT)Realized 20D OHLCV Swing Band: Β±12.5%
Deterministic 5-Pillar Attribution (39/100 Composite)
πŸ” WHY SLQT SCORES 39/100 (D-) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (33% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 4/9

β–² #2 Bullish Driver: Whale & Options Positioning+11/20 pts (28% of score)

20D Institutional Volume Accumulation (Β±12.5% realized swing band)

β–Ό #1 Drag / Risk Factor: Macro Regime Fit4/20 pts (-16 pt drag)

Macro rate sensitivity & RSI-14 (45) create a -16 pt regime headwind

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
31
Grade E$0.35-14.3% Next Q
Q2 (-2Q)
34
Grade E$0.30+16.7% Next Q
Q3 (-1Q)
36
Grade E$0.35+2.9% Next Q
Current
39
Grade D-$0.36-7.6% Hist 90D Ξ±
Trajectory: E (31) β†’ D- (39)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a SLQT Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While SLQT currently carries a cautious 39/100 (D-) rating due to Macro Regime Fit (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.43) and Max Pain ($0.38) forces dealer call-delta covering toward $2.28.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.64% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $SLQTβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œSLQT Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”
SEC FORM 4 Γ— 13F HEDGE FUNDS Γ— CONGRESSIONAL STOCK ACT

SLQT Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales β†’
β–² Disclosed Buys: 0 ($0)β–Ό Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (SLQT)

No recent open-market Form 4 cluster sales or emergency dumps flagged on SLQT. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SLQT)

  • βœ“Walkthrough of SLQT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
SLQT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -55.56%β–² RESISTANCE BREAKOUT
2026-11-03O $0.36H $0.36L $0.36C $0.36VOL 797.7K
RES: $0.35SUP: $0.25SMA50: $0.43SMA200: $0.77
$1.56$1.22$0.88$0.54$0.19RES $0.35SUP $0.25$0.362026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SLQT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
-6.4%/yr Implied 5Y Growth

vs. +15.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on SLQT today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for SLQT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for SLQT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SLQT)

1. Head-to-Head Financials Peer Comparison (SLQT vs. RDZN, HIT, HUIZ, XHG)

Industry: Specialty Insurers (33 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, SelectQuote Inc. (SLQT) ranks #929 by composite RQD confidence (39/100, grade D-) and #1003 by equity capitalization ($64.0M). Within this direct 5-issuer industry benchmark cohort, HIT leads on earnings valuation at 31.2x trailing P/E, while HIT leads on capital efficiency and profitability with 7.5% ROIC and β€” gross margin. HUIZ currently holds the highest overall quantitative score in the immediate peer group at 70/100 (B-) compared with SLQT at 39/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
SLQT ACTIVE
SelectQuote Inc.
D- 39/100 β€” β€” 7.4% -1.38% $64.0M Benchmark Subject
RDZN
Roadzen Inc.
E 20/100 β€” β€” -35.0% +1.79% $97.1M /rdzn-vs-slqt β†’
HIT
Health In Tech Inc. (Class A)
D+ 56/100 31.2x β€” 7.5% -5.61% $37.7M /hit-vs-slqt β†’
HUIZ
Huize Holding Limited
B- 70/100 39.0x β€” 3.1% +0.90% $22.7M /huiz-vs-slqt β†’
XHG
XChange TEC.INC
D- 42/100 β€” β€” β€” +2.52% $209.8M /xhg-vs-slqt β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-06-30 β€’ CIK 0001794783

In its most recent audited fiscal period (FY2025, filed 2025-06-30), SelectQuote Inc. (SLQT) reported GAAP revenue of $1.53B (+15.5% vs. FY2024 revenue of $1.32B , and +52.2% cumulative change since FY2023) , GAAP net income of $47.6M, operating cash flow of -$11.7M, and free cash flow of -$13.9M (-216.9% YoY). On the balance sheet, SLQT closed FY2025 with $1.35B in total assets against $385.7M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-06-30 $1.53B $47.6M -$11.7M -$13.9M $1.35B $385.7M
FY2024 (FY) 2024-06-30 $1.32B -$34.1M $15.2M $11.9M $1.28B $684.3M
FY2023 (FY) 2023-06-30 $1.00B -$58.5M -$19.4M -$19.4M β€” β€”

3. SLQT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SLQT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, SelectQuote Inc. (NYSE: SLQT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $0.36 (-1.38% 1D, market cap $64.0M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 4/20, and SEC Balance-Sheet Forensics 6/20. Across 1096 tracked Financials issuers, SLQT ranks #929 in composite RQD confidence.

How does SLQT compare to RDZN and HIT in the Financials sector?

Within the Financials sector (Specialty Insurers), SLQT carries a Roarable D- (39/100 RQD), trailing P/E of N/A, gross margin of β€”, and ROIC of 7.4%. By comparison, RDZN (Roadzen Inc.) holds a E grade (20/100 RQD, P/E N/A, ROIC -35.0%, cap $97.1M) and HIT (Health In Tech Inc. (Class A)) posts a D+ grade (56/100 RQD, P/E 31.2x, ROIC 7.5%, cap $37.7M). Among the 5-stock peer group, HIT leads on earnings multiple (31.2x) while HIT leads on capital efficiency (7.5% ROIC).

What are the biggest fundamental strengths and SEC risk factors for SLQT?

Per SLQT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001794783), SelectQuote Inc. generated $1.53B in revenue (+15.5% YoY), $47.6M in net income, and -$13.9M in free cash flow against $1.35B in total assets and $385.7M in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is SLQT trading relative to its 50-day, 200-day, and 52-week technical levels?

SLQT last traded at $0.36 (-1.38% on volume of 797,654 shares), positioning the stock -16.28% below its 50-day simple moving average ($0.43) and -53.25% below its 200-day simple moving average ($0.77). Across its 52-week range of $0.30 to $2.17, SLQT sits at the 3.2% percentile with a 14-day RSI of 45.0 (NEUTRAL RANGE) and an implied next-earnings move of Β±12.5% ($1.00 to $0.40).

SLQT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

Are SLQT insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies SLQT leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

ROARABLE RATING BRIEF β€’ RQD 39/100 (D-) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

SLQT β€” SelectQuote Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:46:00Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, SLQT scores 39 out of 100 with a letter grade of D- and the verdict "Roarable Sell β€” Vulnerable Balance Sheet & Flow." The five pillars are: Fundamental Cash Engine at 5/20 (ROIC 7.4%; FCF yield -21.35%), Whale 13F Flow at 11/20 (institutional accumulation and options positioning), Insider Conviction at 6/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 4/20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 13/20 (Altman Z 2.5; Piotroski F 4/9; Debt/Equity 0.5). For a prospective investor, the weakest pillars are the cash engine and macro fit, meaning the rating sees little current free-cash-flow support and limited alignment with the prevailing regime. The forensic balance-sheet score is the strongest pillar, indicating the balance sheet is judged more defensible than the cash generation behind it. The upside case rests mainly on institutional and option positioning, which the rating credits at 11/20, while insider conviction at 6/20 is only moderate. Valuation tradeoffs are visible in the market data: a price of 0.36 against a $64.9M market cap and an EV/EBITDA of 6.1, set against a negative FCF yield. Second-order risk is concentrated in the gap between reported earnings and cash flow, since the rating treats cash generation as the primary weakness.

Business

SelectQuote Inc. (SLQT) is a NYSE-listed issuer classified in the Financials sector and the Specialty Insurers industry, per the profile section. The source data does not detail its products, customer base, or revenue model. Per the financials, the company reported revenue of $1526.6M in FY 2025, indicating a sizable operating base relative to its market capitalization. Gross margin is reported as 0%, and the source data does not explain how revenue is generated or classified.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$1526.6M$68.5M$47.6MN/A$-13.9M$18.3M$385.7M
FY 2024$1321.8M$64.5M$-34.1MN/A$11.9M$7.3M$684.3M
FY 2023$1002.8M$11.6M$-58.5MN/A$-19.4MN/AN/A

Operating margin is reported at 4.5% and net margin at 3.1%, with ROIC at 7.4%. Per the Roarable RQD rating, the Altman Z-Score is 2.5 and the Piotroski F-Score is 4 out of 9, with Debt/Equity at 0.5. Reported debt declined from $684.3M in FY 2024 to $385.7M in FY 2025, while FY 2025 free cash flow was negative at $-13.9M. Net income turned positive in FY 2025 after losses in the prior two periods.

Recent Catalysts & News Wire Analysis

Per the news wire, six items reference SLQT. A Google-aggregated MarketBeat item tagged as a catalyst reports the stock moved up 2.7%. A Yahoo Finance item states SelectQuote is scheduled to release fiscal first quarter 2027 earnings on November 4. Other items are market-wire pieces covering price action, a seasonal returns chart, and a support-level trading note citing a $0.40 shelf. The butterfly supply-chain graph reports no supply chain and no proprietary signals, so no chain-based catalyst is available. Watch items are the November 4 earnings release and the stock's position relative to the $0.40 support level cited in the wire.

Open Questions

  • What drives the FY 2025 revenue of $1526.6M, and how is that revenue classified given the reported 0% gross margin?
  • Why was FY 2025 free cash flow negative at $-13.9M despite positive operating income of $68.5M?
  • What is the composition of the $385.7M debt, and what are its maturity and refinancing terms?
  • What is the outcome of the fiscal first quarter 2027 earnings release scheduled for November 4?
  • Who holds the institutional and insider positions cited in the RQD whale and insider pillars, since the holders section is empty?

SLQT Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for SelectQuote Inc. (SLQT) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to SLQT Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

SLQT Bull vs. Bear Conversation Board β€” What's Your Call at $0.36?

πŸ‚ 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON SLQT 🐻 67% BEARISH CONVICTION
1. Pick Your Side on SLQT:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $0.32 (-11.1%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is SLQT (D- β€’ RQD 39/100) a Buy at $0.36?

Welcome to the SLQT (SelectQuote Inc.) Roar Pit. Current RQD Composite is 39/100 (Roarable Sell β€” Vulnerable Balance Sheet & Flow) in Specialty Insurers. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

BE BearTrap_Alert Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $0.28 (-22.2%)
Spot @ $0.36

Pump the brakes on SLQT β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on SLQT, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless SelectQuote Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

CA CashFlowKing Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $0.45 (+25.0%)
Spot @ $0.36

SLQT cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on SLQT, the market is fixating on short-term headline noise in Specialty Insurers and ignoring the balance sheet and cash flow trajectory. At $0.36 (52-wk range $0.30 - $2.17), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%